Shandong Realcan Pharmaceutical Co Ltd Net Asset Momentum
Shandong Realcan Pharmaceutical Co Ltd net asset momentum. Shandong Realcan Pharmaceutical Co Ltd (002589) recorded a net asset momentum of -4.8% as of December 2025, with net assets of CN¥5.42 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Shandong Realcan Pharmaceutical Co Ltd shareholders equity for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Shandong Realcan Pharmaceutical Co Ltd (2008–2025)
Net asset momentum of Shandong Realcan Pharmaceutical Co Ltd from 2008 to 2025. This chart tracks Shandong Realcan Pharmaceutical Co Ltd's year-over-year net asset growth across 18 annual reporting periods from 2008 to 2025. The most recent momentum reading is -4.8%, with net assets of CN¥5.42 Billion CNY as of December 2025. Check Shandong Realcan Pharmaceutical Co Ltd tangible book value ratio to evaluate the tangible quality of the company's equity base.
Shandong Realcan Pharmaceutical Co Ltd Net Asset Momentum by Year (2008–2025)
Shandong Realcan Pharmaceutical Co Ltd net asset momentum by year from 2008 to 2025. The table below shows the complete annual net asset history for Shandong Realcan Pharmaceutical Co Ltd from 2008 to 2025, covering 18 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see market value of Shandong Realcan Pharmaceutical Co Ltd.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | CN¥5.42 Billion | CN¥14.37 Billion | CN¥8.95 Billion | ▼ -4.8% |
| 2024 | CN¥5.69 Billion | CN¥16.01 Billion | CN¥10.32 Billion | ▲ +1.0% |
| 2023 | CN¥5.64 Billion | CN¥16.71 Billion | CN¥11.07 Billion | ▼ -2.0% |
| 2022 | CN¥5.75 Billion | CN¥18.33 Billion | CN¥12.58 Billion | ▼ -40.7% |
| 2021 | CN¥9.69 Billion | CN¥26.40 Billion | CN¥16.70 Billion | ▲ +0.5% |
| 2020 | CN¥9.64 Billion | CN¥31.29 Billion | CN¥21.65 Billion | ▼ -6.0% |
| 2019 | CN¥10.25 Billion | CN¥32.47 Billion | CN¥22.21 Billion | ▼ -9.3% |
| 2018 | CN¥11.31 Billion | CN¥34.84 Billion | CN¥23.53 Billion | ▲ +16.9% |
| 2017 | CN¥9.67 Billion | CN¥26.98 Billion | CN¥17.31 Billion | ▲ +28.9% |
| 2016 | CN¥7.50 Billion | CN¥15.66 Billion | CN¥8.15 Billion | ▲ +120.4% |
| 2015 | CN¥3.40 Billion | CN¥8.86 Billion | CN¥5.46 Billion | ▲ +86.5% |
| 2014 | CN¥1.83 Billion | CN¥5.68 Billion | CN¥3.85 Billion | ▲ +10.6% |
| 2013 | CN¥1.65 Billion | CN¥4.45 Billion | CN¥2.80 Billion | ▲ +80.1% |
| 2012 | CN¥916.39 Million | CN¥3.12 Billion | CN¥2.20 Billion | ▲ +12.2% |
| 2011 | CN¥817.11 Million | CN¥2.22 Billion | CN¥1.40 Billion | ▲ +176.0% |
| 2010 | CN¥296.03 Million | CN¥1.48 Billion | CN¥1.18 Billion | ▲ +26.4% |
| 2009 | CN¥234.18 Million | CN¥1.04 Billion | CN¥805.78 Million | ▲ +109.3% |
| 2008 | CN¥111.89 Million | CN¥715.53 Million | CN¥603.64 Million | — |